The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin
Open accessAbstract
The flavonoid silibinin, the main compound extracted from the milk thistle Silybum marianum, displays hepatoprotective properties in acute and chronic liver injury. To further elucidate the mechanisms by which it acts, we studied the effects of silibinin on different functions of isolated rat Kupffer cells, namely the formation of superoxide anion radical (0 2 −), nitric oxide (NO), tumor necrosis factor α (TNF- α), prostaglandin E 2 (PGE 2), and leukotriene B 4 (LTB 4). Production of 0 2 − and NO were inhibited in a dose-dependent manner, with an 50% inhibitory concentration (IC 50) value around 80 μmol/L. No effect on TNF-α formation was detected. Opposite effects were found on the cyclooxygenase and 5-lipoxygenase pathway of arachidonic acid metabolism. Whereas no influence on PGE 2 formation was observed with silibinin concentrations up to 100 μmol/L, a strong inhibitory effect on LTB 4 formation became evident. The IC 50- value for inhibiting the formation of this eicosanoid was determined to be 15 μmol/L silibinin. The strong inhibition of LTB 4, formation by silibinin was confirmed in experiments with phagocytic cells isolated from human liver. Hence, while rather high concentrations of silibinin are necessary to diminish free radical formation by activated Kupffer cells, significant inhibition of the 5-lipoxy-genase pathway already occurs at silibinin concentrations which are achieved in vivo. Selective inhibition of leukotriene formation by Kupffer cells can at least partly account for the hepatoprotective properties of silibinin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Prostaglandins, Arachidonic Acid, and Inflammation
Kuehl, F. A., & Egan, R. W. (1980) · Science · doi:10.1126/science.6254151 · Cited by 708
Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
Ferrándiz, M. L., & Alcaraz, M. J. (1991) · Agents and Actions · doi:10.1007/bf01980887 · Cited by 313
Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage
Muriel, P., Garciapiña, T., Perez‐Alvarez, V., & Mourelle, M. (1992) · Journal of Applied Toxicology · doi:10.1002/jat.2550120613 · Cited by 301
Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation
Baumann, J., v. Bruchhausen, F., & Wurm, G. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90103-3 · Cited by 253
Flavonoids: Potent inhibitors of arachidonate 5-lipoxygenase
Yoshimoto, T., Furukawa, M., Yamamoto, S., Horie, T., & Watanabe-Kohno, S. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90568-5 · Cited by 199
Campos, R., Garrido, A., Guerra, R., & Valenzuela, A. (1989) · Planta Medica · doi:10.1055/s-2006-962055 · Cited by 180
PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN
MOURELLE, M., MURIEL, P., FAVARI, L., & FRANCO, T. (1989) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1989.tb00449.x · Cited by 159
Cited by
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,075
The molecular basis of working mechanism of natural polyphenolic antioxidants
Leopoldini, M., Russo, N., & Toscano, M. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.08.012 · Cited by 1,266
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Cutaneous photodamage, oxidative stress, and topical antioxidant protection
Pinnell, S. R. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.16 · Cited by 544
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Gillessen, A., & Schmidt, H. H.-J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01251-y · Cited by 490
Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders
Wellington, K., & Jarvis, B. (2001) · BioDrugs · doi:10.2165/00063030-200115070-00005 · Cited by 479
Polyphenols and their benefits: A review
Rasouli, H., Farzaei, M. H., & Khodarahmi, R. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2017.1354017 · Cited by 476
Hepatoprotective effect of silymarin
Vargas-Mendoza, N. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i3.144 · Cited by 447
Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis
Enjalbert, F., Rapior, S., Nouguier-Soulé, J., Guillon, S., Amouroux, N., & Cabot, C. (2002) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120014646 · Cited by 427
Review of natural products with hepatoprotective effects
Madrigal-Santillán, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14787 · Cited by 385
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Fraschini, F., Demartini, G., & Esposti, D. (2002) · Clinical Drug Investigation · doi:10.2165/00044011-200222010-00007 · Cited by 380
Silybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375
Herbal medicine in the treatment of liver diseases
Stickel, F., & Schuppan, D. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.11.004 · Cited by 364
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Tissue injury by reactive oxygen species and the protective effects of flavonoids
de Groot, H., & Rauen, U. (1998) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00951.x · Cited by 330
Self-citationWadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Boigk, G., Stroedter, L., Herbst, H., Waldschmidt, J., Riecken, E. O., & Schuppan, D. (1997) · Hepatology · doi:10.1002/hep.510260316 · Cited by 293
Herbal products for liver diseases: A therapeutic challenge for the new millennium
Schuppan, D., Jia, J.-D., Brinkhaus, B., & Hahn, E. G. (1999) · Hepatology · doi:10.1002/hep.510300437 · Cited by 279
Complementary and alternative medicine in chronic liver disease
Seeff, L. B., Lindsay, K. L., Bacon, B. R., Kresina, T. F., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.27445 · Cited by 271
Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements
Shalan, M. G., Mostafa, M. S., Hassouna, M. M., El-Nabi, S. E. H., & El-Refaie, A. (2005) · Toxicology · doi:10.1016/j.tox.2004.07.006 · Cited by 264
Silibinin Efficacy against Human Hepatocellular Carcinoma
Varghese, L., Agarwal, C., Tyagi, A., Singh, R. P., & Agarwal, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1646 · Cited by 146
Metadata
- Authors
- Dehmlow, C., Erhard, J., & de Groot, H.
- Venue
- Hepatology
- Published
- 1996-04
- Volume
- 23
- Issue
- 4
- Pages
- 749-754
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1973760627
- Cited by
- 290
- References
- 18
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.